What is the current stock price of Qualigen Therapeutics, Inc. (QLGN)?

As of the latest market data, Qualigen Therapeutics, Inc. (QLGN) is trading at $3.21. The stock has seen a gain of 5.59% today.

Does Qualigen Therapeutics, Inc. (QLGN) pay a dividend?

Based on current data, Qualigen Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Qualigen Therapeutics, Inc.?

The current market capitalization of Qualigen Therapeutics, Inc. (QLGN) is approximately unavailable.

QLGN

Qualigen Therapeutics, Inc.·Healthcare

3.21

5.592%(+0.17)

Market Open

Last Updated: — ET

52W L: $1.6152W H: $8.81

Company Profile

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2015-06-23

Beta

0.28

Websiteqlgntx.com↗